The ultimate compilation of verified healthcare statistics for the Middle East in 2026. Discover market size, pharmaceutical spending, diabetes prevalen...
Middle East Healthcare Market Statistics 2026: Comprehens...
By Sarah Chen
Category: Healthcare Market Research
Executive Summary
The ultimate compilation of verified healthcare statistics for the Middle East in 2026. Discover market size, pharmaceutical spending, diabetes prevalence, oncology growth, and hospital infrastructure data across Saudi Arabia, UAE, and the wider GCC.
Frequently Asked Questions
What is the market size of healthcare in the GCC in 2025?
The overall GCC healthcare market is projected to reach $135.5 billion by 2027, growing at a CAGR of approximately 5.4%. Saudi Arabia dominates this share, accounting for roughly 60% of total expenditure.
How large is the pharmaceutical market in Saudi Arabia?
As of 2024–2025, the Saudi pharmaceutical market is valued at approximately $11.5 billion and is projected to grow at a CAGR of over 5.5% through 2030.
What are the most common diseases in the Middle East?
The Middle East faces a high burden of non-communicable diseases (NCDs). Diabetes prevalence is exceptionally high (over 16% of adults regionally), alongside cardiovascular diseases (responsible for ~35-40% of mortality) and rapidly rising oncology incidence.